[Skip to Content]
[Skip to Content Landing]
Citations 0
Letters
June 2, 1999

Screening for Type 2 Diabetes

Author Affiliations
 

Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999

JAMA. 1999;281(21):1986-1988. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-21-jbk0602

To the Editor: Simulation modeling is a powerful and appropriate tool for examining the possible impact of screening for type 2 diabetes, and we agree with the conclusion of the CDC Diabetes Cost-Effectiveness Study Group that "the selection of appropriate target populations for screening should consider factors in addition to the prevalence of diabetes."1 However, we are concerned that their model disregards some of the important factors that influence outcomes.

×